GlassScriptPhysician profile
Brian R Davis
NPI 1679583470
$1,626.79
in general payments reported to CMS, 2019-2025
14 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2021: $135 · 2022: $441 · 2023: $150 · 2024: $326 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $358.68 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Alcon Vision LLC | $318.51 | 2019-2025 | Total30, Clareon Panoptix Pro, Acrysof Iq Panoptix Uv Iol |
| Sun Pharmaceutical Industries INC. | $155.60 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $138.14 | 2019-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $123.23 | 2019-2023 | |
| Glaukos Corporation | $117.26 | 2024-2025 | Idosetr, Istent Infinite Trabecular Micro Bypass System, Gts100_glaukos Istent Trabecular Micro-Bypass Stent System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.36 | 2019-2021 | |
| Rxsight INC | $72.79 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $65.25 | 2021-2025 | Tecnis Simplicity |
| Kala Pharmaceuticals, INC. | $58.61 | 2021-2022 | |
| Oyster Point Pharma, INC. | $53.63 | 2022-2023 | Tyrvaya |
| Ocular Therapeutix, INC. | $39.66 | 2025 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $37.24 | 2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.